453 related articles for article (PubMed ID: 10629345)
1. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
[TBL] [Abstract][Full Text] [Related]
2. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.
Miller VT; Rothrock JF; Pearce LA; Feinberg WM; Hart RG; Anderson DC
Neurology; 1993 Jan; 43(1):32-6. PubMed ID: 8423907
[TBL] [Abstract][Full Text] [Related]
3. Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation.
Teitelbaum JS; von Kummer R; Gjesdal K; Kristinsson A; Gahn G; Albers GW;
Can J Neurol Sci; 2008 May; 35(2):160-5. PubMed ID: 18574928
[TBL] [Abstract][Full Text] [Related]
4. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
[TBL] [Abstract][Full Text] [Related]
5. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
6. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
[TBL] [Abstract][Full Text] [Related]
7. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.
Eikelboom JW; Hart RG
Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052
[TBL] [Abstract][Full Text] [Related]
9. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
[TBL] [Abstract][Full Text] [Related]
11. The role of warfarin and aspirin in secondary prevention of stroke.
Elkind MS
Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359
[TBL] [Abstract][Full Text] [Related]
12. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.
Deedwania P; Huang GW
Rev Cardiovasc Med; 2012; 13(2-3):e89-104. PubMed ID: 23160166
[TBL] [Abstract][Full Text] [Related]
13. Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation.
Hopps S; Marcy TR
Consult Pharm; 2009 Nov; 24(11):841-4. PubMed ID: 20092222
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
15. Stroke prevention in patients with atrial fibrillation.
Ono A; Fujita T
J Clin Neurosci; 2003 Jan; 10(1):71-3. PubMed ID: 12464526
[TBL] [Abstract][Full Text] [Related]
16. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
Deedwania PC; Huang GW
Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Goldman ME; Pearce LA; Hart RG; Zabalgoitia M; Asinger RW; Safford R; Halperin JL
J Am Soc Echocardiogr; 1999 Dec; 12(12):1080-7. PubMed ID: 10588784
[TBL] [Abstract][Full Text] [Related]
18. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Miller VT; Pearce LA; Feinberg WM; Rothrock JF; Anderson DC; Hart RG
Neurology; 1996 Jan; 46(1):238-40. PubMed ID: 8559383
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]